Show notes
On this episode of our award-winning podcast, Tom continues his discussion with two leading pharmacy experts on what medications and classes of medications are in expedited approval and what this means for patients in overall efficacy and safety, the benefits and the drawbacks. Moderator:Tomas Villanueva, DO, MBA, FACPE, SFHMSenior Principal, Clinical Operations and QualityVizient Guests:Jeni Hayes, PharmD, MSPharm, BCPSSenior Clinical Manager, Pharmacy OutcomesCenter for Pharmacy Practice ExcellenceVizient Steven Lucio, PharmD, BCPSSenior Principal, Pharmacy SolutionsCenter for Pharmacy Practice ExcellenceVizient Show Notes:[[[[[[[ Links | Resources:To contact Modern Practice: [email protected]Steven’s email: [email protected]Jeni’s email: [email protected]FDA’s accelerated approval update page: Click hereVizient Pharmacy Market Highlights – Dec. 2022: PMO322_PharmacyMarketOutlook_Highlights.pdf Subscribe Today!Apple PodcastsAmazon PodcastsAndroidGoogle PodcastsSpotifyStitcherRSS Feed

